Artificial intelligence in psoriasis: Where we are and where we are going

被引:7
|
作者
Liu, Zhenhua [1 ,2 ]
Wang, Xinyu [3 ]
Ma, Yao [4 ]
Lin, Yiting [2 ]
Wang, Gang [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Shaanxi, Peoples R China
[2] Fourth Mil Med Univ, Tangdu Hosp, Dept Dermatol, 1 Xinsi Rd, Xian 710038, Shaanxi, Peoples R China
[3] Valdosta State Univ, Dept Econ Finance & Healthcare Adm, Valdosta, GA 31602 USA
[4] Fourth Mil Med Univ, Student Brigade Basic Med Sch, Xian, Peoples R China
基金
中国国家自然科学基金;
关键词
artificial intelligence; deep learning; dermatology; machine learning; psoriasis; CONVOLUTIONAL NEURAL-NETWORKS; RISK STRATIFICATION; SEVERITY INDEX; MACHINE VISION; SKIN-CANCER; SEGMENTATION; CLASSIFICATION; MANAGEMENT; ARTHRITIS; IMAGES;
D O I
10.1111/exd.14938
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Artificial intelligence (AI) is a field of computer science that involves the development of programs designed to replicate human cognitive processes and the analysis of complex data. In dermatology, which is predominantly a visual-based diagnostic field, AI has become increasingly important in improving professional processes, particularly in the diagnosis of psoriasis. In this review, we summarized current AI applications in psoriasis: (i) diagnosis, including identification, classification, lesion segmentation, lesion severity and area scoring; (ii) treatment, including prediction treatment efficiency and prediction candidate drugs; (iii) management, including e-health and preventive medicine. Key challenges and future aspects of AI in psoriasis were also discussed, in hope of providing potential directions for future studies.
引用
收藏
页码:1884 / 1899
页数:16
相关论文
共 50 条
  • [41] 'WHERE ARE WE, WHERE HAVE WE COME FROM, WHERE ARE WE GOING'
    BOLTON, K
    OVERLAND, 1991, (123): : 52 - 53
  • [42] WHERE WERE WE, WHERE ARE WE, WHERE ARE WE GOING, AND WHO CARES
    WOOLSEY, G
    INTERFACES, 1993, 23 (05) : 40 - 46
  • [43] Where have we been? Where are we now? Where are we going?
    Aronoff, GM
    CLINICAL JOURNAL OF PAIN, 1997, 13 (01): : 3 - 5
  • [44] Major Marketing Traditions - Where Are We, Where Are We Going, and Where We Should Be Going and Why?
    Moller, Kristian
    AUSTRALASIAN MARKETING JOURNAL, 2007, 15 (01): : 37 - 38
  • [45] ARTIFICIAL-INTELLIGENCE - WHERE ARE WE
    BOBROW, DG
    HAYES, PJ
    ARTIFICIAL INTELLIGENCE, 1985, 25 (03) : 375 - 415
  • [46] Where We Are and Where We Are Going in Nut Research
    Salas-Salvado, Jordi
    Nishi, Stephanie K.
    Sabate, Joan
    Ros, Emilio
    NUTRIENTS, 2023, 15 (07)
  • [47] WHERE HAVE WE BEEN AND WHERE ARE WE GOING
    SCHUTZ, CA
    GENERATIONS-JOURNAL OF THE AMERICAN SOCIETY ON AGING, 1995, 19 (02): : 33 - 34
  • [48] CANCER OF THE RECTUM - WHERE ARE WE - WHERE ARE WE GOING
    WELCH, JP
    WELCH, CE
    ARCHIVES OF SURGERY, 1993, 128 (06) : 697 - 702
  • [49] NUCLEAR SHIPMENTS - WHERE WE ARE AND WHERE ARE WE GOING
    BROBST, WA
    TRANSACTIONS OF THE AMERICAN NUCLEAR SOCIETY, 1976, 23 (JUN18): : 88 - 88
  • [50] Childhood Stuttering: Where Are We and Where Are We Going?
    Smith, Anne
    Weber, Christine
    SEMINARS IN SPEECH AND LANGUAGE, 2016, 37 (04) : 291 - 297